Almoosa Health Co. reported a net profit of SAR 102.9 million for H1 2025, compared to SAR 12.5 million in the year-earlier period.
Item | 6m 2024 | 6m 2025 | Change |
---|---|---|---|
Revenues | 561.75 | 671.95 | 19.6 % |
Gross Income | 153.71 | 210.88 | 37.2 % |
Operating Income | 51.54 | 102.20 | 98.3 % |
Net Income | 12.47 | 102.90 | 725.4 % |
Average Shares | 35.00 | 44.30 | 26.6 % |
Earnings Per Share before unusual items (Riyals) | 0.36 | 2.34 | 555.8 % |
EPS (Riyal) | 0.36 | 2.32 | 552.1 % |
The profit growth was attributed to a 19.6% rise in revenues, reaching SAR 671.9 million in the six-month period.
This growth was mainly driven by strong performance across various operating segments, an increase in the number of inpatients, improved efficiency in the utilization of healthcare services, and lower financing costs (FCs) following the settlement of a loan earlier in the year.
Item | Q2 2024 | Q2 2025 | Change |
---|---|---|---|
Revenues | 284.59 | 348.97 | 22.6 % |
Gross Income | 75.17 | 112.09 | 49.1 % |
Operating Income | 20.90 | 54.14 | 159.0 % |
Net Income | (1.26) | 51.77 | 4208.6 % |
Average Shares | 35.00 | 44.30 | 26.6 % |
Earnings Per Share before unusual items (Riyal) | (0.04) | 1.21 | 3460.6 % |
EPS (Riyal) | (0.04) | 1.17 | 3345.8 % |
Item | Q1 2025 | Q2 2025 | Change |
---|---|---|---|
Revenues | 322.98 | 348.97 | 8.0 % |
Gross Income | 98.79 | 112.09 | 13.5 % |
Operating Income | 48.06 | 54.14 | 12.7 % |
Net Income | 51.13 | 51.77 | 1.3 % |
Average Shares | 44.30 | 44.30 | - |
Earnings Per Share before unusual items (Riyal) | 1.13 | 1.21 | 7.4 % |
EPS (Riyal) | 1.15 | 1.17 | 1.3 % |
Net earnings for Q2 2025 soared to SAR 51.8 million, against a loss of SAR 1.26 million in Q2 2024.
On a sequential basis, net profit grew 1.3% from SAR 51.1 million in Q1 2025.
Total shareholders’ equity (no minority interest) rose to SAR 1.9 billion by June 30, 2025, compared to SAR 633.1 million in the prior-year period.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: